Black Diamond Therapeutics Inc (NAS:BDTX)
$ 3.31 0.09 (2.8%) Market Cap: 187.03 Mil Enterprise Value: 82.76 Mil PE Ratio: 0 PB Ratio: 1.68 GF Score: 41/100

Black Diamond Therapeutics Inc at Cowen Health Care Conference Transcript

Mar 06, 2023 / 05:50PM GMT
Release Date Price: $1.81 (-2.16%)
Marc Frahm
TD Cowen - Analyst

Welcome to the TD Cowen Health Care Conference. I'm Marc Frahm from the biotech team. Really happy to have -- next up is Black Diamond Therapeutics and the CEO, David Epstein, who's going to discuss the programs right now in lung cancer and GBM that are in the clinic as well some that are nearing the clinic. And then if we have time at the end, we will have some Q&A where Sergey, the CMO, will also join us. With that, I'll hand it over to David.

David Epstein
Black Diamond Therapeutics, Inc. - Co-Founder, President & CEO

Thank you, Marc. So can you hear me? Okay. So thank you and welcome to this afternoon's presentation. Really excited to be here and talk about what we're doing at Black Diamond Therapeutics. So before getting into that, I do want to remind everybody that the presentation contains forward-looking statements, particularly with respect to our clinical programs, our discovery programs, and our use of proceeds.

This is an exciting year for Black Diamond Therapeutics. It's a catalyst-rich year. So we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot